Taaha Amin Mendha

Taaha Mendha practices at Sylvester Comprehensive Cancer Center in Miami, Florida, part of University of Miami.

Taaha Mendha's NPI, 1215497250, was assigned on March 25, 2019. Taaha Mendha holds Florida license ME155813.

Taaha Mendha's primary practice is Sylvester Comprehensive Cancer Center, at 1475 Nw 12th Ave, Miami, FL 33136.

Taaha Mendha's primary practice is Sylvester Comprehensive Cancer Center in Miami, Florida, part of University of Miami. The medical group on file is University of Miami Health System. Dmand AI also links Taaha Mendha to 1 more group practice or clinic and 1 home health agency, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Taaha Mendha practices, 3 sites in all. Vendor and product names are available with a free account.

Internal medicine is Taaha Mendha's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Taaha Mendha is licensed in Florida.

CMS data shows 523 Medicare services from Taaha Mendha across 3 procedure codes in 2024, for 175 Medicare patients. Medicare paid $40,233 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 175 Medicare patients who saw Taaha Mendha in 2024. The largest group is 75 to 84, with 64 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 52% are also on Medicaid. Their average risk score is 3.65, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Taaha Mendha's median patient age at 71, with 52% women.

In 2024, Taaha Mendha wrote 724 Medicare Part D claims for 239 patients. 84% of them were for generic drugs. CMS names the drug for 359 of them, across 17 drugs with 11 or more claims each, at $37,502 in total drug cost. In 2023, CMS named 109 claims across 7 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Taaha Mendha for performance year 2024, reported as part of a group. Taaha Mendha accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 4 papers to Taaha Mendha, published from 2018 to 2023. 2023 was the busiest year, with 2. Taaha Mendha has published most often in Cureus. Taaha Mendha's most frequent co-authors are Van Anh Do, MD, Mohamed Atef Mohamed Elmahdy Hamed and Ahmed Lababidi, MD.

CMS Open Payments shows 1 general payment to Taaha Mendha from 1 drug or device company in 2022. Food and beverage make up the largest share, 100% of the total. Novartis Pharmaceuticals Corporation paid the most, $15.